HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

deladroxate

contains algestone acetophenide and estradiol enanthate

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Hyperplasia 04/01/1994 - "Some of the toxicological problems for Deladroxate, for instance, included pituitary hyperplasia development in rats, a carry-over effect, and estradiol accumulation. " 04/01/1994 - "A longitudinal study indicated that there is no accumulation of norethisterone after 12 months of treatment with NET-EN 50 mg and estradiol valerate 5 mg. About 1 million women in Latin America and China have used the 1st generation once-a-month combined injectable contraceptives Deladroxate and Chinese Injectable No. 1. Animal toxicity studies of Deladroxate found pituitary hyperplasia in rats, breast tumors in beagles, and accumulation of estradiol enanthate in the body. "
2.	Breast Neoplasms (Breast Cancer) 04/01/1994 - "A longitudinal study indicated that there is no accumulation of norethisterone after 12 months of treatment with NET-EN 50 mg and estradiol valerate 5 mg. About 1 million women in Latin America and China have used the 1st generation once-a-month combined injectable contraceptives Deladroxate and Chinese Injectable No. 1. Animal toxicity studies of Deladroxate found pituitary hyperplasia in rats, breast tumors in beagles, and accumulation of estradiol enanthate in the body. "
3.	Gastroenteritis 10/01/1969 - " These 2 groups of babies lost weight in the first 4 weeks and 5 died of gastroenteritis: 3 from the Deladroxate group and 2 from the Lyndiol 2.5 group. "

Related Drugs and Biologics

1.	Estradiol (Delestrogen)
2.	Norethindrone (Norethisterone)
3.	Contraceptive Agents (Contraceptives)
4.	Injectable No. 1
5.	estradiol enanthate
6.	Noracycline

Related Therapies and Procedures

1.	Injections